UB Paderborn / Katalog / Suche / in CDI

Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2011-03, Vol.14 (1), p.72-80

2011

Link zum Volltext

Verfügbarkeit prüfen

Questionnaire Survey From the Viewpoint of Concordance in Patient and Physician Satisfaction Concerning Hypertensive Treatment in Elderly Patients　― Patients Voice Study

Circulation Journal, 2018/03/23, Vol.82(4), pp.1051-1061

2018

Link zum Volltext

Verfügbarkeit prüfen

A dose-finding approach based on shrunken predictive probability for combinations of two agents in phase I trials

Statistics in medicine, 2013-11, Vol.32 (26), p.4515-4525

2013

Link zum Volltext

Verfügbarkeit prüfen

Meta-Analysis of Postoperative Adjuvant Chemotherapy With Tegafur-Uracil in Non–Small-Cell Lung Cancer

Journal of clinical oncology, 2005-08, Vol.23 (22), p.4999-5006

2005

Link zum Volltext

Verfügbarkeit prüfen

Two-stage approach based on zone and dose findings for two-agent combination Phase I/II trials

Journal of biopharmaceutical statistics, 2018-11, Vol.28 (6), p.1025-1037

2018

Link zum Volltext

Verfügbarkeit prüfen

Clinical Signatures of Mucinous and Poorly Differentiated Subtypes of Colorectal Adenocarcinomas by a Propensity Score Analysis of an Independent Patient Database from Three Phase III Trials

Diseases of the colon & rectum, 2018-04, Vol.61 (4), p.461-471

2018

Link zum Volltext

Verfügbarkeit prüfen

Effect of subcutaneous tocilizumab treatment on work/housework status in biologic-naïve rheumatoid arthritis patients using inverse probability of treatment weighting: FIRST ACT-SC study

Arthritis research & therapy, 2018-07, Vol.20 (1), p.151-151, Article 151

2018

Link zum Volltext

Verfügbarkeit prüfen

Response to tocilizumab and work productivity in patients with rheumatoid arthritis: 2-year follow-up of FIRST ACT-SC study

Modern rheumatology, 2021, Vol.31 (1), p.42-52

2021

Link zum Volltext

Verfügbarkeit prüfen

Analyses of drug combinations using missing data shortens trial periods in phase I/II oncology trials

Contemporary clinical trials communications, 2017-09, Vol.7, p.73-80

2017

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and safety of S-1 and oxaliplatin combination therapy in elderly patients with advanced gastric cancer

Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2016-07, Vol.19 (3), p.919-926

2016

Link zum Volltext

Verfügbarkeit prüfen

The role of meta-analysis in cancer clinical trials

International journal of clinical oncology, 2009-04, Vol.14 (2), p.90-94

Hamada, Chikuma

2009

Link zum Volltext

Verfügbarkeit prüfen

A pragmatic dose-finding approach using short-term surrogate efficacy outcomes to evaluate binary efficacy and toxicity outcomes in phase I cancer clinical trials

Pharmaceutical statistics : the journal of the pharmaceutical industry, 2013-09, Vol.12 (5), p.315-327

2013

Link zum Volltext

Verfügbarkeit prüfen

Development and validation of a prognostic nomogram for colorectal cancer after radical resection based on individual patient data from three large-scale phase III trials

Oncotarget, 2017-11, Vol.8 (58), p.99150-99160

2017

Link zum Volltext

Verfügbarkeit prüfen

Preplanned safety analysis of the JFMC37-0801 trial: a randomized phase III study of six months versus twelve months of capecitabine as adjuvant chemotherapy for stage III colon cancer

International journal of clinical oncology, 2017-06, Vol.22 (3), p.494-504

2017

Link zum Volltext

Verfügbarkeit prüfen

Bayesian Model Averaging Continual Reassessment Method for Bivariate Binary Efficacy and Toxicity Outcomes in Phase I Oncology Trials

Journal of biopharmaceutical statistics, 2014-03, Vol.24 (2), p.310-325

2014

Link zum Volltext

Verfügbarkeit prüfen

Sleeve lung resection for lung cancer: Analysis according to the type of procedure

The Journal of thoracic and cardiovascular surgery, 2008-11, Vol.136 (5), p.1349-1356

2008

Link zum Volltext

Verfügbarkeit prüfen

Analysis of medication incident for improvement of medication process

Total quality management & business excellence, 2013-08, Vol.24 (7-8), p.859-868

2013

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 243

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(191)
Mit Volltextzugriff
(222)

Publikationsform

Artikel
(243)

Sprache

Englisch
(190)
Japanisch
(120)
Deutsch
(1)
Chinesisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Statistical analysis for toxicity studies

An adaptive dose-finding method using a change-point model for molecularly targeted agents in phase I trials

TAS-102 monotherapy for pretreated metastatic colorectal cancer: a double-blind, randomised, placebo-controlled phase 2 trial

Cilostazol for prevention of secondary stroke (CSPS 2): an aspirin-controlled, double-blind, randomised non-inferiority trial

Risk Factors for Peritoneal Recurrence in Stage II to III Colon Cancer

Dose individualization and variable selection by using the Bayesian lasso in early phase dose finding trials

Phase III randomised trial comparing 6 vs. 12-month of capecitabine as adjuvant chemotherapy for patients with stage III colon cancer: final results of the JFMC37-0801 study

Interim decision-making strategies in adaptive designs for population selection using time-to-event endpoints

Randomized phase III study comparing the efficacy and safety of irinotecan plus S-1 with S-1 alone as first-line treatment for advanced gastric cancer (study GC0301/TOP-002)

Questionnaire Survey From the Viewpoint of Concordance in Patient and Physician Satisfaction Concerning Hypertensive Treatment in Elderly Patients　― Patients Voice Study

A dose-finding approach based on shrunken predictive probability for combinations of two agents in phase I trials

Meta-Analysis of Postoperative Adjuvant Chemotherapy With Tegafur-Uracil in Non–Small-Cell Lung Cancer

Two-stage approach based on zone and dose findings for two-agent combination Phase I/II trials

Clinical Signatures of Mucinous and Poorly Differentiated Subtypes of Colorectal Adenocarcinomas by a Propensity Score Analysis of an Independent Patient Database from Three Phase III Trials

Effect of subcutaneous tocilizumab treatment on work/housework status in biologic-naïve rheumatoid arthritis patients using inverse probability of treatment weighting: FIRST ACT-SC study

Response to tocilizumab and work productivity in patients with rheumatoid arthritis: 2-year follow-up of FIRST ACT-SC study

Analyses of drug combinations using missing data shortens trial periods in phase I/II oncology trials

Efficacy and safety of S-1 and oxaliplatin combination therapy in elderly patients with advanced gastric cancer

The role of meta-analysis in cancer clinical trials

A pragmatic dose-finding approach using short-term surrogate efficacy outcomes to evaluate binary efficacy and toxicity outcomes in phase I cancer clinical trials

Development and validation of a prognostic nomogram for colorectal cancer after radical resection based on individual patient data from three large-scale phase III trials

Preplanned safety analysis of the JFMC37-0801 trial: a randomized phase III study of six months versus twelve months of capecitabine as adjuvant chemotherapy for stage III colon cancer

Bayesian Model Averaging Continual Reassessment Method for Bivariate Binary Efficacy and Toxicity Outcomes in Phase I Oncology Trials

Sleeve lung resection for lung cancer: Analysis according to the type of procedure

Analysis of medication incident for improvement of medication process

Suchergebnisse filtern